Cullinan Oncology, Inc. (CGEM) - Quarterly Income Statement

Home
CGEM
Financials

11.6 (USD) • At close December 20, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1
Revenue Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	-37.848	0	0	18.943	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0.077	0.076	0.077	0.08	0.081	0.072	0.059	0.009	0	0	0.012	0.013	0.013	0	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	0	-0.077	-0.076	-0.077	-0.08	-0.081	-0.072	-0.059	-0.009	0	0	-37.86	-0.013	-0.013	18.943	0	0	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	35.506	36.259	30.646	34.848	33.821	27.391	52.096	21.321	19.68	26.411	24.536	20.878	12.68	11.778	12.415	16.629	9.913	12.496	4.173	3.802	5.276	3.855	3.855
General & Administrative Expenses Numbers are in millions	13.349	13.768	12.343	10.637	10.982	10.214	10.66	11.287	10.086	10.695	8.121	13.468	5.695	4.826	5.156	12.544	1.586	1.626	1.368	1.177	1.477	1.214	1.214
Selling & Marketing Expenses Numbers are in millions	0	-0.077	-0.076	-0.077	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0.1
SG&A Numbers are in millions	13.349	13.691	12.267	10.56	10.982	10.214	10.66	11.287	10.086	10.695	8.121	13.468	5.695	4.826	5.156	12.544	1.586	1.626	1.368	1.177	1.677	1.314	1.314
Other Expenses Numbers are in millions	0	-0.072	-0.044	-0.117	0.18	0.069	0.107	0.298	0	-0.241	0	0.004	-0.002	-0.008	-0.002	-0.012	0	0.001	0	0	0	0	0
Operating Expenses Numbers are in millions	48.855	49.95	42.913	45.408	44.803	37.605	62.756	32.608	29.766	37.106	32.657	34.346	18.375	16.604	17.571	29.173	11.499	14.122	5.541	4.979	6.95	5.171	5.171
Operating Income Numbers are in millions	-48.855	-50.027	-42.989	-45.485	-45.243	-37.605	-62.756	-32.608	-29.766	239.679	-32.657	-34.346	-18.375	-16.604	1.372	-29.173	-11.499	-14.122	-5.541	-4.979	-6.953	-5.169	-5.169
Operating Income Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0.907	0	0	0.072	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	8.295	7.999	5.649	5.8	6.06	5.391	4.615	3.662	2.353	0.456	0.197	0.141	0.116	0.165	0.047	0.067	0.185	0.247	0.378	0.248	0.104	0.132	0.132
Income Before Tax Numbers are in millions	-40.56	-42.028	-37.34	-39.685	-39.183	-32.214	-58.141	-28.946	-27.413	240.135	-32.46	-34.205	-18.259	-16.439	1.419	-29.106	-11.314	-13.875	-5.163	-4.731	-6.849	-5.037	-5.037
Income Before Tax Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0.904	0	0	0.075	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	0	-0.192	-14.122	-5.44	-5.403	-0.179	-1.858	-2.523	66.07	-19.568	0.223	-1.027	-0.976	1.425	6.899	-1.456	-5.499	-0.19	-0.162	-0.266	-0.285	-0.285
Net Income Numbers are in millions	-40.56	-42.028	-37.148	-23.803	-39.183	-32.214	-57.962	-27.088	-24.89	174.898	-12.892	-32.513	-17.35	-15.636	-0.07	-28.346	-9.858	-8.622	-4.973	-4.569	-6.583	-4.753	-4.753
Net Income Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0.859	0	0	-0.004	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.7	-0.76	-0.86	-0.56	-0.92	-0.81	-1.42	-0.59	-0.55	3.9	-0.29	-0.76	-0.4	-0.36	-0.002	-0.68	-0.26	-0.45	-0.26	-0.24	-6.83	-5.94	-5.94
EPS Diluted Numbers are in millions	-0.7	-0.76	-0.86	-0.56	-0.92	-0.81	-1.42	-0.59	-0.55	3.77	-0.29	-0.74	-0.4	-0.36	-0.002	-0.68	-0.26	-0.45	-0.26	-0.24	-6.82	-5.94	-5.94
EBITDA Numbers are in millions	-48.779	-49.95	-42.913	-45.408	-44.723	-37.524	-62.684	-34.549	-29.757	-35.394	-32.644	-34.335	-18.362	-16.591	1.387	-29.091	-11.484	-13.859	-5.525	-4.962	-6.937	-5.151	-5.151
EBITDA Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0.907	0	0	0.072	0	0	0	0	0	0	0	0

Cullinan Oncology, Inc.

NASDAQ:CGEM Add to watchlist

NASDAQ:CGEM